| Key Financial Ratios of Shukra Pharmaceuticals (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
0.22 |
16.93 |
26.21 |
4.79 |
0.22 |
|
| Diluted EPS (Rs.) |
0.22 |
16.93 |
26.21 |
4.79 |
0.22 |
|
| Cash EPS (Rs.) |
0.29 |
18.81 |
15.95 |
15.41 |
9.63 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
1.44 |
52.65 |
64.63 |
104.43 |
99.63 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
1.44 |
52.65 |
64.63 |
104.43 |
99.63 |
|
| Dividend / Share(Rs.) |
0.01 |
1.00 |
0.50 |
0.50 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
0.74 |
68.12 |
150.31 |
130.84 |
71.51 |
|
| PBDIT/Share (Rs.) |
0.39 |
20.30 |
16.76 |
18.95 |
11.50 |
|
| PBIT/Share (Rs.) |
0.32 |
18.42 |
12.07 |
8.33 |
2.09 |
|
| PBT/Share (Rs.) |
0.30 |
18.16 |
11.35 |
6.50 |
0.63 |
|
| Net Profit/Share (Rs.) |
0.22 |
16.93 |
11.26 |
4.79 |
0.22 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
51.97 |
29.79 |
11.15 |
14.48 |
16.07 |
|
| PBIT Margin (%) |
42.75 |
27.04 |
8.02 |
6.36 |
2.91 |
|
| PBT Margin (%) |
40.92 |
26.66 |
7.54 |
4.96 |
0.87 |
|
| Net Profit Margin (%) |
29.38 |
24.85 |
7.48 |
3.66 |
0.30 |
|
| Return on Networth / Equity (%) |
15.23 |
32.16 |
17.41 |
4.59 |
0.21 |
|
| Return on Capital Employed (%) |
20.04 |
31.66 |
14.54 |
5.73 |
1.14 |
|
| Return on Assets (%) |
11.03 |
23.81 |
5.87 |
2.13 |
0.09 |
|
| Total Debt/Equity (X) |
0.07 |
0.05 |
0.20 |
0.21 |
0.63 |
|
| Asset Turnover Ratio (%) |
0.40 |
0.98 |
1.07 |
0.59 |
0.33 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
3.79 |
3.97 |
1.25 |
1.27 |
2.46 |
|
| Quick Ratio (X) |
3.21 |
3.81 |
1.17 |
0.95 |
2.19 |
|
| Inventory Turnover Ratio (X) |
1.91 |
4.89 |
3.19 |
3.93 |
1.93 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.37 |
1.77 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.34 |
1.25 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
99.63 |
98.23 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
99.66 |
98.75 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
948.82 |
350.65 |
19.48 |
12.75 |
16.23 |
|
| EV/Net Operating Revenue (X) |
29.12 |
4.70 |
0.33 |
0.62 |
1.45 |
|
| EV/EBITDA (X) |
56.02 |
15.78 |
2.97 |
4.30 |
9.02 |
|
| MarketCap/Net Operating Revenue (X) |
29.36 |
4.79 |
0.31 |
0.46 |
0.62 |
|
| Retention Ratios (%) |
0.00 |
99.62 |
98.22 |
0.00 |
0.00 |
|
| Price/BV (X) |
15.23 |
6.20 |
0.73 |
0.58 |
0.45 |
|
| Price/Net Operating Revenue |
29.36 |
4.79 |
0.31 |
0.46 |
0.62 |
|
| Earnings Yield |
0.01 |
0.05 |
0.24 |
0.08 |
0.00 |
|
Source : Dion Global Solutions Limited
